| ²é¿´: 166 | »Ø¸´: 2 | |||
| µ±Ç°Ö÷ÌâÒѾ´æµµ¡£ | |||
³½ÁúÔÚÌìÌú¸Ëľ³æ (СÓÐÃûÆø)
|
[½»Á÷]
·ÒëÁ½¾ä»°£¨ÃâÒßÏà¹ØµÄ£©
|
||
|
10¸ö½ð±Ò·ÒëÁ½¾ä»°£¬Ð»Ð»´ó¼Ò Most significantly in this study, the antigen (TT) and adjuvant (R6F) were not administered in admixture but at separate sites according to a ¡®Two-Site Immunization Method (TSIM)¡¯ developed in our laboratory. The ability of oral R6F to enhance parenterally immunized antigen suggests an alternative mode of action as conventional adjuvants are thought to rely on physicochemical interactions including the maintenance of antigenic conformation and depot-related effects that stimulate immune activation¡£ R6FÊÇÁùζµØ»ÆÍ裬 TTÊÇÆÆÉË·çÀà¶¾ËØ |
» ²ÂÄãϲ»¶
Ò»Ö¾Ô¸ ½ÄÏ´óѧ 085602 »¯¹¤×¨Ë¶ 338·ÖÇóµ÷¼Á
ÒѾÓÐ14È˻ظ´
312Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
070300»¯Ñ§Ñ§Ë¶311·ÖÇóµ÷¼Á
ÒѾÓÐ13È˻ظ´
²ÄÁϵ÷¼Á
ÒѾÓÐ9È˻ظ´
Ò»Ö¾Ô¸ºÓ±±¹¤Òµ´óѧ²ÄÁϹ¤³Ì£¬³õÊÔ344Çóר˶µ÷¼Á
ÒѾÓÐ4È˻ظ´
²ÄÁÏר˶322
ÒѾÓÐ8È˻ظ´
Ò»Ö¾Ô¸211£¬»¯Ñ§Ñ§Ë¶£¬310·Ö£¬±¾¿ÆÖصãË«·Ç£¬Çóµ÷¼Á
ÒѾÓÐ13È˻ظ´
0703»¯Ñ§
ÒѾÓÐ14È˻ظ´
µ÷¼Á Ò»Ö¾Ô¸¼ªÁÖ´óѧ357·Ö
ÒѾÓÐ3È˻ظ´
»¯Ñ§µ÷¼Á
ÒѾÓÐ18È˻ظ´

jiaql
ľ³æ (ÕýʽдÊÖ)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 7082.5
- Ìû×Ó: 914
- ÔÚÏß: 70.2Сʱ
- ³æºÅ: 115980
- ×¢²á: 2005-11-24
- רҵ: ÄÜÔ´»¯¹¤
¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
³½ÁúÔÚÌì(½ð±Ò+10,VIP+0):·ÒëµÄºÜÇå³þ£¬Ð»Ð» 6-4 15:16
³½ÁúÔÚÌì(½ð±Ò+10,VIP+0):·ÒëµÄºÜÇå³þ£¬Ð»Ð» 6-4 15:16
| ͨ¹ýÎÒÃÇʵÑéÊÒÌá³öµÄ˫λÃâÒßÁÆ·¨£¬±¾Ñо¿·¢ÏÖÁËÒ»¸öÖØÒªµÄÏÖÏ󣬯ÆÉË·çÀà¶¾ËØºÍ¸¨×ôÒ©ÎïÁùζµØ»ÆÍèÖ»ÄÜ·Ö¿ªµ¥¶ÀʹÓ㬶ø²»ÄÜͬʱÓÃÓÚÖÎÁÆ¡£ÓÉÓÚ´«Í³µÄÒ©ÎïÌí¼Ó¼Á±»ÈÏΪÊÇÒÀ¿¿Ï໥µÄÎïÀí»¯Ñ§×÷ÓÃÈç±£³Ö¿¹ÔµÄ¹¹Ïó¼°¸¨Öú×÷ÓÃÀ´¼¤»îÃâÒßÄÜÁ¦£¬Òò´Ë£¬ÓÃÓÚ¿Ú·þµÄÁùζµØ»ÆÍè¶Ô×¢ÉäÓÃÒ©ÎԵÄÃâÒßÁ¦µÄÌá¸ßΪÎÒÃÇÌṩÁËÒ»Öֿɹ©Ñ¡ÔñµÄ×÷Ó÷½Ê½¡£ |
2Â¥2009-06-04 14:43:48
³½ÁúÔÚÌì
Ìú¸Ëľ³æ (СÓÐÃûÆø)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 7125.6
- É¢½ð: 3
- Ìû×Ó: 261
- ÔÚÏß: 18.6Сʱ
- ³æºÅ: 582892
- ×¢²á: 2008-07-25
- ÐÔ±ð: GG

3Â¥2009-06-04 15:21:56














»Ø¸´´ËÂ¥